Skip to content
Taxonomy
Research in Charcot–Marie–Tooth Disease Type 1A (CMT1A) CMT1A Research Since 2008, the CMTA-STAR has made historic progress Read More
CMTA and Addex Announce CMT1A Collaboration CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B Read More
CMTA-STAR Biotech & Alliance Partners Since 2008, STAR has invested more than $17 million in funding to CMT research. Currently, the STAR Drug Development Pipeline involves more than 30 research partners participating in more than 50 research studies.Pharnext Premier PXT3003 for CMT1A Phase 3 Study PREMIER is a Phase 3 clinical study of a study Read More
Research Project: CMT Biomarkers and Outcome Measures Dear Patients and Families affected by Charcot Marie Tooth Disease Read More
All Other Types OTHER TYPES OF CMT: STRATEGY Although there are more than Read More
Find Research by My CMT Type/Subtype CMT forms are usually either demyelinating or axonal in nature, Read More
CMT2F Research CMT2F Dominant mutations in HSPB1 have been reported to cause Read More
Unidentified Type 2 CMT Research Unidentified Type 2 CMT While researchers have identified more than Read More
CMT2S Research CMT2S CMT2S was first discovered by Dr. Ellen Cottenie in Read More
